by Jordana Choucair | Jun 17, 2022 | Life Sciences
A newly unsealed whistleblower suit claims that multiple CVS Health subsidiaries coordinated to prevent members from accessing generic drugs. According to the lawsuit, CVS’ SilverScripts Part D subsidiary as well as its Caremark pharmacy benefit manager and...
by Jordana Choucair | Jun 17, 2022 | Mental Health
Just in time for Father’s Day, Senior Director Tym Rourke wrote a guest blog for the Partnership @drugfree NH that explores navigating fatherhood in the “new normal.” Tym shares his and his family’s personal experience weathering changes and challenges during the...
by Jordana Choucair | Jun 17, 2022 | Providers
Kaiser Permanente formally launched a new Center for Gun Violence Research and Education. The center, which was initially announced May 29, focuses on preventing gun violence through research, and education, and care innovation efforts. In tandem with the launch, the...
by Jordana Choucair | Jun 16, 2022 | Access & Coverage
President Joe Biden’s top aides might issue executive orders to preserve abortion rights for women in Republican-led states should the Supreme Court follow through on its draft opinion to strike down Roe v. Wade. According to senior administration officials, the...
by Jordana Choucair | Jun 16, 2022 | Life Sciences
A committee of advisers to the Food and Drug Administration (FDA) voted unanimously to recommend that the agency authorize COVID-19 vaccines from Moderna and Pfizer-BioNTech for children as young as 6 months. The agency is expected to authorize the vaccines soon. A...
by Jordana Choucair | Jun 16, 2022 | Life Sciences
Moderna Inc. is planning to test its COVID-19 vaccine in babies 3 months to 6 months old, the youngest age group studied to date. The biotech company said it is in the final stages of planning the “BabyCove” study and expects to begin enrolling as many as 700 babies...
Recent Comments